Shufeng Ji

423 total citations
17 papers, 301 citations indexed

About

Shufeng Ji is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shufeng Ji has authored 17 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Shufeng Ji's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Cancer-related gene regulation (3 papers). Shufeng Ji is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Cancer-related gene regulation (3 papers). Shufeng Ji collaborates with scholars based in China, Macao and United States. Shufeng Ji's co-authors include Guoli Shao, Aiguo Wu, Mengchuan Wang, Jian Zhang, Zixiang Wang, Pusheng Zhang, Lin Zhong, Peng Liu, Lei Huang and Huafeng Yang and has published in prestigious journals such as Journal of Biomedical Materials Research Part A, Journal of Translational Medicine and Cancer Biology & Therapy.

In The Last Decade

Shufeng Ji

15 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shufeng Ji China 11 172 125 79 58 35 17 301
Zhonghai Guan China 8 280 1.6× 189 1.5× 78 1.0× 46 0.8× 43 1.2× 18 370
Pei Jou Chua Singapore 10 230 1.3× 112 0.9× 103 1.3× 27 0.5× 32 0.9× 12 346
Zhangwei Tong China 9 235 1.4× 106 0.8× 90 1.1× 38 0.7× 41 1.2× 17 347
Jiawen Tian China 7 171 1.0× 87 0.7× 91 1.2× 32 0.6× 33 0.9× 10 315
Qiqi Shi China 9 322 1.9× 161 1.3× 89 1.1× 48 0.8× 57 1.6× 16 458
Chunxu Yang China 10 254 1.5× 104 0.8× 68 0.9× 88 1.5× 25 0.7× 15 356
Yunfei Yan China 11 289 1.7× 178 1.4× 53 0.7× 30 0.5× 39 1.1× 27 384
Yingxia Ning China 10 212 1.2× 147 1.2× 109 1.4× 23 0.4× 49 1.4× 20 354
Jeannette Huaman United States 6 155 0.9× 111 0.9× 73 0.9× 26 0.4× 48 1.4× 7 310

Countries citing papers authored by Shufeng Ji

Since Specialization
Citations

This map shows the geographic impact of Shufeng Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufeng Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufeng Ji more than expected).

Fields of papers citing papers by Shufeng Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufeng Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufeng Ji. The network helps show where Shufeng Ji may publish in the future.

Co-authorship network of co-authors of Shufeng Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Shufeng Ji. A scholar is included among the top collaborators of Shufeng Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufeng Ji. Shufeng Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhong, Lin, J.Z. Zhu, Haibo Liu, et al.. (2025). MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer. Cancer Biology & Therapy. 26(1). 2475604–2475604.
2.
Zheng, Jianwei, Qianqian Wang, June X. Zou, et al.. (2024). Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma. Cell Reports Medicine. 5(5). 101519–101519. 8 indexed citations
3.
Ji, Shufeng, et al.. (2023). Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer. Journal of Translational Medicine. 21(1). 721–721. 10 indexed citations
4.
Shao, Guoli, et al.. (2022). Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis. Cell Biology and Toxicology. 39(5). 2183–2205. 12 indexed citations
5.
6.
Shao, Guoli, Mengchuan Wang, Lin Zhong, et al.. (2019). lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster. International Journal of Oncology. 54(5). 1665–1675. 28 indexed citations
7.
Shao, Guoli, et al.. (2018). Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis. Technology in Cancer Research & Treatment. 17. 1876021672–1876021672. 13 indexed citations
8.
Wang, Mengchuan, Jian Zhang, Shufeng Ji, et al.. (2017). Transarterial chemoembolisation for breast cancer with liver metastasis: A systematic review. The Breast. 36. 25–30. 20 indexed citations
9.
Wang, Mengchuan, Jian Zhang, Shufeng Ji, et al.. (2017). Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells. Medical Science Monitor. 23. 3904–3912. 53 indexed citations
10.
Ji, Shufeng & Lin Zhong. (2016). [A preliminary functional study of AT motif binding factor 1 in colorectal cancer].. PubMed. 36(7). 957–63. 1 indexed citations
11.
Wu, Aiguo, Guoli Shao, Shufeng Ji, et al.. (2015). DNAzyme-based probe for circulating microRNA detection in peripheral blood. Drug Design Development and Therapy. 9. 6109–6109. 3 indexed citations
12.
Wang, Mengchuan, et al.. (2015). Autophagic regulation of cell growth by altered expression of Beclin 1 in triple-negative breast cancer.. PubMed. 8(5). 7049–58. 33 indexed citations
13.
Ji, Shufeng, et al.. (2015). 浅谈轮椅训练对康复患者的影响. New Century Science Press LLC - Global Journal of Clinical Report. 1(2). 5–5.
14.
15.
Ji, Shufeng, Guoli Shao, Xiaobin Lv, et al.. (2013). Downregulation of miRNA‐128 sensitises breast cancer cell to chemodrugs by targeting Bax. Cell Biology International. 37(7). 653–658. 22 indexed citations
16.
Wang, Jinling, Jianhong Ye, Shufeng Ji, et al.. (2012). A cellular delivery system fabricated with autologous BMSCs and collagen scaffold enhances angiogenesis and perfusion in ischemic hind limb. Journal of Biomedical Materials Research Part A. 100A(6). 1438–1447. 22 indexed citations
17.
Ji, Shufeng, Aiguo Wu, & Huafeng Yang. (2012). [Expression of progesterone receptor membrane component-1 is associated with the malignant phenotypes of breast cancer].. PubMed. 32(5). 635–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhonghai Guan Breakdown of academic impact, for papers by Pei Jou Chua Breakdown of academic impact, for papers by Zhangwei Tong Breakdown of academic impact, for papers by Jiawen Tian Breakdown of academic impact, for papers by Qiqi Shi Breakdown of academic impact, for papers by Chunxu Yang Breakdown of academic impact, for papers by Yunfei Yan Breakdown of academic impact, for papers by Yingxia Ning Breakdown of academic impact, for papers by Jeannette Huaman
Rankless by CCL
2026